We are providing a €20 million loan to Universal DX for innovative early cancer detection tests.
The funding will support the development and commercialization of cutting-edge blood-based liquid biopsy solutions.
🔗 https://bit.ly/EIB_UniversalDX
The funding will support the development and commercialization of cutting-edge blood-based liquid biopsy solutions.
🔗 https://bit.ly/EIB_UniversalDX
Comments